Thomas A Clark

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. pmc Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital
    Thomas A Clark
    Epidemic Intelligence Service, Epidemiology Program Office, Division of Applied Public Health Training, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 42:4468-72. 2004
  2. doi request reprint Pertussis control: time for something new?
    Thomas A Clark
    Centers for Disease Control and Prevention, Division of Bacterial Diseases, 1600 Clifton Road, Mailstop C 25, Atlanta, GA 30333, USA
    Trends Microbiol 20:211-3. 2012
  3. pmc Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine
    Paul A Kristiansen
    Norwegian Institute of Public Health, Oslo, Norway
    BMC Infect Dis 13:363. 2013
  4. ncbi request reprint Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Amanda C Cohn
    Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC, USA
    MMWR Recomm Rep 62:1-28. 2013
  5. ncbi request reprint Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998-2009
    Elizabeth C Briere
    Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS C 25, Atlanta, GA 30333, USA
    Pediatrics 130:414-20. 2012
  6. doi request reprint Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011
    Loren Rodgers
    Epidemic Intelligence Service, Scientific Education and Professional Development Program Office, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 56:322-31. 2013
  7. doi request reprint Qualitative assessment of pertussis diagnostics in United States laboratories
    Kathleen M Tatti
    From the Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases, Meningitis and Vaccine Preventable Diseases Branch, Atlanta, GA
    Pediatr Infect Dis J 32:942-5. 2013
  8. doi request reprint Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States
    Sema Mandal
    Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS C 25, Atlanta, GA 30329, USA
    Clin Infect Dis 57:344-8. 2013
  9. pmc Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt
    SARA TARTOF
    Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    PLoS ONE 8:e63605. 2013
  10. doi request reprint Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis
    Andrew Terranella
    National Center forImmunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA USA
    Pediatrics 131:e1748-56. 2013

Collaborators

Detail Information

Publications26

  1. pmc Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital
    Thomas A Clark
    Epidemic Intelligence Service, Epidemiology Program Office, Division of Applied Public Health Training, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Clin Microbiol 42:4468-72. 2004
    ..parapsilosis bloodstream infections in adults resulted from an interplay of host, environment, and pathogen factors. Recommendations for control measures focused on improving hand hygiene compliance...
  2. doi request reprint Pertussis control: time for something new?
    Thomas A Clark
    Centers for Disease Control and Prevention, Division of Bacterial Diseases, 1600 Clifton Road, Mailstop C 25, Atlanta, GA 30333, USA
    Trends Microbiol 20:211-3. 2012
    ..However, waning of immunity from acellular vaccines may be driving the recent resurgence of pertussis, raising the need to consider new prevention strategies...
  3. pmc Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine
    Paul A Kristiansen
    Norwegian Institute of Public Health, Oslo, Norway
    BMC Infect Dis 13:363. 2013
    ..The aim of this study was to genetically characterize meningococcal isolates circulating in Burkina Faso before and up to 13 months after MenAfriVac mass vaccination...
  4. ncbi request reprint Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Amanda C Cohn
    Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC, USA
    MMWR Recomm Rep 62:1-28. 2013
    ..Guidelines for antimicrobial chemoprophylaxis and for evaluation and management of suspected outbreaks of meningococcal disease also are provided...
  5. ncbi request reprint Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998-2009
    Elizabeth C Briere
    Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS C 25, Atlanta, GA 30333, USA
    Pediatrics 130:414-20. 2012
    ..In response to a limited vaccine supply that began in 2007, Hib booster doses were deferred for 18 months...
  6. doi request reprint Epidemiologic and laboratory features of a large outbreak of pertussis-like illnesses associated with cocirculating Bordetella holmesii and Bordetella pertussis--Ohio, 2010-2011
    Loren Rodgers
    Epidemic Intelligence Service, Scientific Education and Professional Development Program Office, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 56:322-31. 2013
    ..The majority of cases were identified by IS481-directed polymerase chain reaction (PCR), which does not differentiate among Bordetella species. We sought to determine outbreak etiology and epidemiologic characteristics...
  7. doi request reprint Qualitative assessment of pertussis diagnostics in United States laboratories
    Kathleen M Tatti
    From the Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases, Meningitis and Vaccine Preventable Diseases Branch, Atlanta, GA
    Pediatr Infect Dis J 32:942-5. 2013
    ..PCR testing for pertussis is rapid and sensitive, but the lack of standardization and variable specificity is concerning...
  8. doi request reprint Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States
    Sema Mandal
    Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS C 25, Atlanta, GA 30329, USA
    Clin Infect Dis 57:344-8. 2013
    ..Unlike that for serogroups prevented by quadrivalent meningococcal vaccines, public health response to outbreaks of serogroup B meningococcal disease is limited by lack of a US licensed vaccine...
  9. pmc Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt
    SARA TARTOF
    Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    PLoS ONE 8:e63605. 2013
    ..We developed an age-structured mathematical model of MenA transmission, colonization, and disease in the African meningitis belt, and used this model to explore the impact of various vaccination strategies...
  10. doi request reprint Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis
    Andrew Terranella
    National Center forImmunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA USA
    Pediatrics 131:e1748-56. 2013
    ..ACIP recommends pregnancy vaccination as a preferred and safe alternative to postpartum vaccination. The ACIP cocooning recommendation has not changed...
  11. doi request reprint Waning immunity to pertussis following 5 doses of DTaP
    Sara Y Tartof
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Pediatrics 131:e1047-52. 2013
    ..To assess the risk of pertussis by time since vaccination in children in Minnesota and Oregon who received 5 doses of acellular pertussis vaccines (DTaP)...
  12. doi request reprint Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010
    Lara K Misegades
    Epidemic Intelligence Service and Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS C25, Atlanta, GA 30329, USA
    JAMA 308:2126-32. 2012
    ....
  13. doi request reprint Early Impact of the US Tdap vaccination program on pertussis trends
    Tami H Skoff
    Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mail Stop C 25, Atlanta, GA 30333, USA
    Arch Pediatr Adolesc Med 166:344-9. 2012
    ..To evaluate the impact of the adolescent Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine) vaccination program on pertussis trends in the United States...
  14. doi request reprint Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data
    Ryan T Novak
    Centers for Disease Control and Prevention, Atlanta, GA 30329, USA
    Lancet Infect Dis 12:757-64. 2012
    ..We analysed national surveillance data around PsA-TT introduction to investigate the early effect of the vaccine on meningitis incidence and epidemics...
  15. pmc Haemophilus haemolyticus isolates causing clinical disease
    Raydel Anderson
    Meningitis and Vaccine Preventable Disease Branch, Division of Bacterial Diseases, National Center for Infectious and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Clin Microbiol 50:2462-5. 2012
    ..All cases had different symptoms and presentations. Our study suggests that a testing scheme that includes reliable PCR assays and standard microbiological methods should be used in order to improve H. haemolyticus identification...
  16. ncbi request reprint Bordetella holmesii bacteremia cases in the United States, April 2010-January 2011
    Sara Y Tartof
    Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia
    Clin Infect Dis 58:e39-43. 2014
    ..These cases occurred during a peak in pertussis outbreaks with documented cases of B. holmesii/Bordetella pertussis respiratory coinfection; whether there is a link between B. holmesii respiratory and bloodstream infection is unknown. ..
  17. doi request reprint Practice patterns of infectious disease physicians for management of meningococcal disease
    Andrew Terranella
    Epidemic Intelligence Service, Scientific, Education, and Professional Development Office, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 31:e208-12. 2012
    ..A survey was conducted among infectious disease specialists to assess meningococcal disease practice patterns and availability of antimicrobial susceptibility testing for Neisseria menigitidis...
  18. doi request reprint Pertussis Pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA From clinic surfaces
    Sema Mandal
    Epidemic Intelligence Service, Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention, Atlanta, GA 30329, USA
    Pediatrics 129:e424-30. 2012
    ..We aimed to determine whether Bordetella pertussis was the causative agent and advise on control interventions...
  19. ncbi request reprint Changing pertussis epidemiology: everything old is new again
    Thomas A Clark
    Centers for Disease Control and Prevention, Atlanta, Georgia
    J Infect Dis 209:978-81. 2014
    ..Though acellular vaccines have been in use for 20 years, new data are emerging on their effectiveness and durability of protection and the contribution of these characteristics to the resurgence of pertussis. ..
  20. ncbi request reprint CDC update on pertussis surveillance and Tdap vaccine recommendations
    Thomas A Clark
    Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease and Control and Prevention, Atlanta, GA, USA
    NASN Sch Nurse 27:297-300. 2012
    ..The school nurse is in a critical position to create awareness and influence action-related national and state recommendations for the Tdap vaccine...
  21. pmc Modeling insights into Haemophilus influenzae type b disease, transmission, and vaccine programs
    Michael L Jackson
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Emerg Infect Dis 18:13-20. 2012
    ....
  22. ncbi request reprint Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel
    Manisha Patel
    Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS C 25, Atlanta, GA 30333, USA Electronic address
    Vaccine 32:3805-9. 2014
    ..66μg/mL at 3 years, and significantly lower than the MPSV4 group at all time-points. Anti-MenC responses wane following vaccination with MenACYWD; a booster dose is needed to maintain protective levels of circulating antibody. ..
  23. pmc Accuracy of real-time PCR, Gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosis
    Henry M Wu
    Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, GA 30333, USA
    BMC Infect Dis 13:26. 2013
    ..CSF Gram staining and real-time PCR are theoretically less affected by antibiotics; however, it is difficult to evaluate these tests with an imperfect reference standard...
  24. doi request reprint MCV vaccination in the presence of vaccine-associated Guillain-Barré Syndrome risk: a decision analysis approach
    Bo Hyun Cho
    McKing Consulting Corporation, 1600 Clifton Rd NE MS E 52, Atlanta, GA 30333, USA
    Vaccine 28:817-22. 2010
    ..Based on the result, MCV4 vaccination is strongly favored despite possible vaccine-associated GBS risk...
  25. pmc SARS clinical features, United States, 2003
    Padmini Srikantiah
    Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    Emerg Infect Dis 11:135-8. 2005
    ..Shortness of breath, vomiting, diarrhea, progressive bilateral infiltrates on chest radiograph, and need for supplemental oxygen were significantly associated with confirmed SARS-CoV infection...
  26. ncbi request reprint Recent trends in the epidemiology of invasive mycoses
    Thomas A Clark
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Curr Opin Infect Dis 15:569-74. 2002
    ..In addition, advances in therapeutic technologies and in particular the development of novel immunosuppressive therapies have prolonged the period of risk for many individuals...